Current medical options for autoimmune diabetes are based in treatment with insulin; despite the numerous advances in the formulation, duration and stability of several types of insulins (5), the most significant change in the management of diabetes is due to continuous and recent advances in diabetes-applied technologies, including glucose monitoring systems (6, 7). The gene discussed is INS; the disease is diabetes mellitus.